logo
Select company
Select metric
$ -129.57MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
10
Sector
7
Industry
6
History
27
$ 2.97Close
$ 0.51 - $ 5.18 52-Week Range
Ticker Information

Ticker

PROK

Company Name

PROKIDNEY CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROKIDNEY CORP - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PROK - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -129.57M
3/31/2025$ 13.42M
12/31/2024$ 38.47M
9/30/2024$ -83.3M
6/30/2024$ -29.05M
3/31/2024$ -187.25M
12/31/2023$ -429.6M
9/30/2023$ -314.94M
6/30/2023$ 555.94M
3/31/2023$ 241.83M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROKIDNEY CORP's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 440.49K.
  • Over the past 5 years, PROKIDNEY CORP's average CF - Chg. Cash has been $ 12.17M.
  • The median CF - Chg. Cash for PROKIDNEY CORP during this period was $ -14.3M
  • PROKIDNEY CORP reached its highest CF - Chg. Cash over the past 5 years at $ 555.94M.
  • The lowest CF - Chg. Cash recorded by PROKIDNEY CORP in the same timeframe $ -429.6M

PROKIDNEY CORP's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
SEPN : SEPTERNA INC $ 58.14MMREO : MEREO BIOPHARMA GROUP PLC $ -33.82MABEO : ABEONA THERAPEUTICS INC $ 129.11MCRDF : CARDIFF ONCOLOGY INC $ -14.72MAVTX : AVALO THERAPEUTICS INC $ -51.04MBBOT : BRIDGEBIO ONCOLOGY THERAPEUTICS INC $ 29.59MCOYA : COYA THERAPEUTICS INC $ -6.82MMNMD : MIND MEDICINE (MINDMED) INC $ -209.74MSANA : SANA BIOTECHNOLOGY INC $ -63.32MERNA : ERNEXA THERAPEUTICS INC $ -2.37M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

PROK - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -429.6M

Minimum

Dec 31, 2023

$ 555.94M

Maximum

Jun 30, 2023

$ 12.17M

Average

$ -14.3M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M